These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 19479486)

  • 1. Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questions.
    Tang SC
    Cancer Invest; 2009 Jun; 27(5):489-95. PubMed ID: 19479486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to decrease taxanes toxicities in the adjuvant treatment of early breast cancer.
    Tang SC
    Cancer Invest; 2009 Feb; 27(2):206-14. PubMed ID: 19235594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials.
    Estévez LG; Muñoz M; Alvarez I; Fernández Y; García-Mata J; Ruiz-Borrego M; Tusquets I; Seguí MA; Rodríguez-Lescure A; Adrover E; Lluch A
    Cancer Treat Rev; 2007 Aug; 33(5):474-83. PubMed ID: 17561350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.
    Piccart-Gebhart MJ; Burzykowski T; Buyse M; Sledge G; Carmichael J; Lück HJ; Mackey JR; Nabholtz JM; Paridaens R; Biganzoli L; Jassem J; Bontenbal M; Bonneterre J; Chan S; Basaran GA; Therasse P
    J Clin Oncol; 2008 Apr; 26(12):1980-6. PubMed ID: 18421049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
    Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti FR; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso SI; Lopez M
    Clin Ter; 2008; 159(6):453-6. PubMed ID: 19169608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxanes as primary chemotherapy for early breast cancer: meta-analysis of randomized trials.
    Cuppone F; Bria E; Carlini P; Milella M; Felici A; Sperduti I; Nisticò C; Terzoli E; Cognetti F; Giannarelli D
    Cancer; 2008 Jul; 113(2):238-46. PubMed ID: 18470908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
    Herceg D; Vrbanec D
    Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes.
    Rivera E
    Am J Clin Oncol; 2010 Apr; 33(2):176-85. PubMed ID: 19675449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of nonanthracycline regimens in the adjuvant treatment of breast cancer.
    Pal SK; Childs BH; Pegram M
    Breast Cancer Res Treat; 2010 Jan; 119(1):25-32. PubMed ID: 19795206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trends.
    Moreno-Aspitia A; Perez EA
    Clin Ther; 2009 Aug; 31(8):1619-40. PubMed ID: 19808124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined anthracycline-taxane regimens in the adjuvant setting.
    Mamounas EP; Sledge GW
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):24-31. PubMed ID: 11552227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant taxanes: more to the story.
    Gajria D; Seidman A; Dang C
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S41-9. PubMed ID: 20805064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer.
    Martin M; Mackey J; Vogel C
    Breast; 2007 Dec; 16 Suppl 2():S127-31. PubMed ID: 17923408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in adjuvant chemotherapy for breast cancer: the role of taxanes.
    Kaklamani VG; Gradishar WJ
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S107-18. PubMed ID: 19795584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma.
    Bria E; Giannarelli D; Felici A; Peters WP; Nisticò C; Vanni B; Cuppone F; Cognetti F; Terzoli E
    Cancer; 2005 Feb; 103(4):672-9. PubMed ID: 15637696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: a meta-analysis of phase III randomized control trials.
    Shao N; Wang S; Yao C; Xu X; Zhang Y; Zhang Y; Lin Y
    Breast; 2012 Jun; 21(3):389-93. PubMed ID: 22542064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes.
    Murphy CG; Seidman AD
    Clin Breast Cancer; 2009 Jun; 9 Suppl 2():S58-65. PubMed ID: 19596644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy--the dark side of clinical trials. Have we learnt more?
    Oakman C; Pestrin M; Cantisani E; Licitra S; DeStefanis M; Biganzoli L; Di Leo A
    Breast; 2009 Oct; 18 Suppl 3():S18-24. PubMed ID: 19914536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxanes in the treatment of early breast cancer.
    Ring AE; Ellis PA
    Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New combination chemotherapy regimens in the primary treatment of operable breast cancer].
    Conti F; Sergi D; Foggi P; Abbate MI; Lopez M
    Clin Ter; 2007; 158(1):55-75. PubMed ID: 17405660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.